Opioid shopping behavior: How often, how soon, which drugs, and what payment method

Journal of Clinical Pharmacology

Volumn 53, Issue 1, 2013, Pages 112-117

  Cepeda, M Soledad ^a   Fife, Daniel ^a   Chow, Wing ^a   Mastrogiovanni, Gregory ^b   Henderson, Scott C ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b IQVIA   (United States)

Author keywords

Abuse; Cohort study; Diversion; Misuse; Opioids; Shopping behavior

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DRUG ABUSE; DRUG EXPOSURE; DRUG FORMULATION; DRUG MISUSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OPIOID SHOPPING BEHAVIOR; PATIENT ATTITUDE; PHARMACY; PRESCRIPTION; RISK FACTOR; SHOPPING;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG-SEEKING BEHAVIOR; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PHARMACIES; PHYSICIANS; UNITED STATES; YOUNG ADULT;

EID: 84877846860     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270012436561     Document Type: Article

References (21)

1. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA . 2007;297(3):249-251.
2. Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep . 2011;60(43):1487-1492.
3. McLellan AT, Turner BJ. Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann Intern Med . 2010;152(2):123-124.
4. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend . 2006;81(2):103-107.
5. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA . 2008;300(22): 2613-2620.
6. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: National Findings. 2007. http://www.oas.samhsa.gov/nsduh/2k6nsduh/2k6Results pdf
7. Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf . 2010;19(2):115-123.
8. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care . 2009;15(12):897-906.
9. Parente ST, Kim SS, Finch MD, et al. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am J Manag Care . 2004;10(11, pt 1):783-790.
10. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan BJ, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and Medicaid insurance plans: the TROUP Study. Pain . 2010;150(2):332-339.
11. Pradel V, Frauger E, Thirion X, et al. Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiol Drug Saf . 2009;18(1):36-43.
12. Pradel V, Thirion X, Ronfle E, Masut A, Micallef J, Begaud B. Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database. Pharmacoepidemiol Drug Saf . 2004;13(7):473-481.
13. Cepeda MS, Fife D, Chow W, Mastrogiovanni G, Henderson SC. Assessing opioid shopping behavior: a large cohort study from a medication dispensing database. Drug Saf . In press.
14. US Department of Health and Human Services. Understanding health information privacy. 2011. http://www.hhs.gov/ocr/privacy/hipaa/understanding/ index.html
15. Drug Enforcement Administration. Controlled substance schedules. 2011. http://www.deadiversion.usdoj.gov/schedules/index.html
16. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage . 2008;35(2):214-228.
17. Schneider MF, Bailey JE, Cicero TJ, et al. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf . 2009;18(9):778-790.
18. Michna E, Duh MS, Korves C, Dahl JL. Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications. Pain Med . 2010;11(3):369-378.
19. Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL. "We don't carry that"-failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med . 2000;342(14):1023-1026.
20. Sullivan MD, Edlund MJ, Steffick D, Unntzer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain . 2005;119(1-3):95-103.
21. Page LA, Henderson M. Appraising the evidence: what is measurement bias? Evid Based Ment Health . 2008;11(2):36-37.